1
TÍTULO: Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial  Full Text
AUTORES: Valesca P Retel; Danalyn Byng; Sabine C Linn; Katarzyna Joezwiak; Hendrik Koffijberg; Emiel J Rutgers; Fatima Cardoso; Martine J Piccart; Coralie Poncet; Laura J van't Veer; Wim H van Harten;
PUBLICAÇÃO: 2020, FONTE: EUROPEAN JOURNAL OF CANCER, VOLUME: 137
INDEXADO EM: WOS
2
TÍTULO: Benchmarking Cancer Centers: From Care Pathways to Integrated Practice Units
AUTORES: Wind, A; Goncalves, FR ; Marosi, E; da Pieve, L; Groza, M; Asioli, M; Albini, M; van Harten, W;
PUBLICAÇÃO: 2018, FONTE: JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, VOLUME: 16, NÚMERO: 9
INDEXADO EM: Scopus WOS CrossRef: 7
3
TÍTULO: Development of a benchmark tool for cancer centers; results from a pilot exercise  Full Text
AUTORES: Wind, A; van Dijk, J; Nefkens, I; van Lent, W; Nagy, P; Janulionis, E; Helander, T; Rocha Goncalves, F ; van Harten, W;
PUBLICAÇÃO: 2018, FONTE: BMC HEALTH SERVICES RESEARCH, VOLUME: 18, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef: 6
4
TÍTULO: A general model for cancer centers to conduct health technology assessments; a practical case of next generation sequencing in oncology  Full Text
AUTORES: Retel, V; Mewes, J; Wind, A; Rocha Goncalves, F ; Van Harten, W;
PUBLICAÇÃO: 2017, FONTE: ECCO European Cancer Congress in EUROPEAN JOURNAL OF CANCER, VOLUME: 72
INDEXADO EM: WOS CrossRef
5
TÍTULO: Management and performance features of cancer centers in Europe: A fuzzy-set analysis  Full Text
AUTORES: Anke Wind; Mariana Fernandes Lobo ; Joris van Dijk; Isabelle Lepage Nefkens; Jose Laranja Pontes; Vitor da Conceicao Goncalves; Wim van Harten; Francisco Nuno Rocha Goncalves ;
PUBLICAÇÃO: 2016, FONTE: JOURNAL OF BUSINESS RESEARCH, VOLUME: 69, NÚMERO: 11
INDEXADO EM: Scopus WOS CrossRef: 2